Back to search

France· FR:68725005

OXEOL 10 mg, comprimé sécable

A bambuterol product containing chlorhydrate de bambutérol, registered in France by ASTRAZENECA, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R03CC12

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedOXEOL 10 mg, comprimé sécableATCR03CC12REGISTER NO.FR:68725005PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Bambuterol is registered in 4 of 19 countries.

Countries holding a registration under ATC R03CC12 (bambuterol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Bambuterol · ATC R03CC12

4 / 19 countries

  • Franceprice
  • Germany
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bambuterol costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.45 in France to $0.76 in Spain — a ×1.7 gap.

  • France: $0.45 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Bambuterol · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.76
  • FR France$0.45
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE BAMBUTÉROL
Manufacturer
ASTRAZENECA
Country
France (FR)
ATC code
R03CC12
ATC class
Bambuterol
Defined daily dose
20 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933713751
    plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s)
    EUR 5.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bambuterol in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bambuterol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Austria · Bambec
  • Germany · Bambec
  • United Kingdom (Northern Ireland) · Bambec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9210101-c32e-4fe9-b289-4535fc5958dd
GET /v1/drugs/e9210101-c32e-4fe9-b289-4535fc5958dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68725005",
  "date_amm": "1994-02-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE BAMBUTÉROL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé sécable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about bambuterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.